Document Details

Uploaded by Deleted User

Michelle Mabasa

Tags

liver enzymes liver function tests diagnosis medicine

Summary

This document provides an overview of liver enzymes, including their functions, tests, and significance in diagnosing liver damage. It details different enzymes, their common tests, and their practical applications in a clinical setting.

Full Transcript

CC2 Lab – Prelims – PART 3 Ma’am Michelle Mabasa LIVER ENZYMES Liver Function Test  The conjugation function of your liver is the ability of...

CC2 Lab – Prelims – PART 3 Ma’am Michelle Mabasa LIVER ENZYMES Liver Function Test  The conjugation function of your liver is the ability of your liver to metabolize bilirubin or  Tests Measuring Hepatic Synthetic Function urobilinogen o TPAG  Excretion is the ability of the liver to produce bile o PT  Dili pagawason ni liver si ammonia kundi iya ra I  Tests Measuring conjugation and Excretion detoxify and convert into urea ( nontoxic form) o Bilirubin  You can then use ammonia as a detoxification o Urobilinogen function test  Tests for Detoxification Function o An increase ammonia in the blood would o Enzyme mean there is a problem in the liver  ALP  AMINOTRANSFERASES Enzyme Tests  5’N  GGT  Used to assess the extent of liver damage  LDH  Cytolysis and Necrosis  Any injury in the liver can  Differentiate hepatocellular from obstructive lead to the liberation of disease the enzymes  Common liver enzymes: o Ammonia o ALP (alkaline phosphatase)  Is a protein catabolism result but o AMINOTRANSFERASES is very toxic which is why ammonia  AST (aspartate is converted to urea aminotransferase)  Urea is nontoxic substance and  ALT (alanine aminotransferase) can easily be eliminated through o 5’N the kidney via the urine o GGT (gamma-glutamyl transferase) o LDH (lactate dehydrogenase) Note: o OCT – not commonly performed  Liver is the gatekeeper to determine whether a Note: particular substance can be release on the circulation or out on the trash  Remember that enzymes are large molecules so  Functions of the liver: they are bound inside the cell. In a situation 1. Storage where there is cytolysis or necrosis, they would 2. Synthetic function be liberated (mang gawas na sila kay namatay naman ang cell)  Liver is able to produce o This then results into their freedom unto  Proteins the circulation  Enzymes  Which can cause an increase of  Carbohydrates enzyme in blood  Clotting factors  Hepatocellular – there is a problem in the  The synthetic function of the liver is assessed hepatocytes (cells of the liver) through performing  Hepatocellular pertains to functional disorder  total protein albumin (TPAG) o Problems on the hepatocytes (liver cells)  Prothrombin Time (PT)  Obstructive pertains to mechanical disorder o Has clotting factors which are synthesized in the liver CC2 Lab – Prelims – PART 3 Ma’am Michelle Mabasa o asically obstructive means naa bay nag Note: bara. This is in the form of  ALT – ALANINE AMINOTRANSFERASE  Gallstones  Tumor  Old name SGPT – Serum glutamic pyruvic  Etc. transaminase  General Classification – Transferases/ Transaminase ALT (SGPT)  Catalyzes same catalytic reaction with AST (EC 2.6.1.2) o Transfers amino group  The difference between AST and ALT with regards to their catalytic reaction is.. o AST – Aspartate o ALT – Alanine  CATALYTIC REACTION o Transfer of amino group from your alanine to your α-keto-glutarate which producecs pyruvate acid and glutamate acid.  Higher levels of ALT and AST are seen in hepatocellular disorders rather than intra or extra  Co-factor hepatic obstruction o Pyridoxal Phosphate  The only screening test we do for blood donors are  Major Tissue Source o Transfusion transmittable infection o Liver  HIV  Specific enzyme  Hepa C,A  Because majority is  Syphilis found on the liver  Malari  Minor Tissue source  In US, ALT is included in the screening of blood o Kidney donors as mandated by the IFCC because o Pancreas o ALT is a good marker for post transfusion o RBC hepatitis o Heart  If ALT is increase, the patient o Lungs doesn’t qualify o Skeletal muscle  Significance o Evaluation of hepatic disorders  All liver disease even in acute Methods of Determination phase, ALT and AST elevates  Karmen Method  Mas taas tho si ALT  Remain elevated – 2-6 weeks  In acute inflammatory condition of the liver, ALT increase  Reitman-Frankel o Used to screen blood donors  Not practiced in our country  Reference value: 6-37 U/L CC2 Lab – Prelims – PART 3 Ma’am Michelle Mabasa Note: Laboratory Considerations  Karmen method  Serum or heparinized plasma free from o Coupled enzymatic reaction hemolysis o On the 1st reaction  Aminotransferases are present in human  It catalyzes first the transfer of o Plasma amino group from alanine and o Bile ketoglutarate with ALT o CSF producing pyruvate and o saliva glutamate. (refer to the photo above)  Vitamin B6 can hinder the patients who have the o On the 2nd reaction deficiency in vitamin B6  Pyruvate will react with NADH in o Have falsely low or normal ALT result the presence of your indicator o Vitamin B6 is pyridoxal phosphate or a enzyme called LD cofactor  LD – is a redox reaction o Without the cofactor, slow ang reaction  The oxidation reduction of sa enzyme NADH to NAD is the one being  Certain drugs and alcohol may also increase ALT measured activity o Decrease in absorbance of oxidation of  Stability of enzyme activity can be maintained by NADH to NAD is directly proportional to refrigeration of the sample for up to 3 days and the activity of ALT freezing the sample for up to 30 days o The decrease in absorbance on a o Refrigerator – 3 days continuous monitoring technique is o Freezer – 30 days measured o Read at 340 nm in 37 °C  Reitman-Frankel Note: o Coupled enzymatic reaction o On the 1st reaction  No hemolysis as there are minor concentration  Same with Karmen method of ALT found in RBC where there is catalytic transfer of amino group from alanine and AST/SGOT ALT/SGPT ketoglutarate producing Major Organ Heart Liver pyruvate and l-glutamate. Affected o On the 2nd reaction Substrate Aspartic Alpha Alanine Alpha  Pyruvate is made to react with Ketoglutaric Acid Ketoglutaric Acid DNPH in alkaline condition End products Glutamic acid + Glutamic acid + where a colored complex is Oxaloacetic acid Pyruvic acid formed Color Developer 2,4 DNPH 2,4 DNPH o The activity of the colored complex is Color intensifier 0.4N NaOH 0.4N NaOH directly proportional to the ALT activity Methods Reitman and Reitman and Frankel Frankel o Change of absorbance in colored Karmen complex is measured in 500 nm Note: o Read at 500 nm  The major organ affected by AST is the heart which is why it is part of the cardiac markers  ALT is on liver since its liver specific CC2 Lab – Prelims – PART 3 Ma’am Michelle Mabasa ALP o Hepatobiliary – disorder in (EC 3.1.3.1)  Liver  We have isoenzyme specific for liver  gallbladder  bile duct o bone disorder  such as paget’s disease  ALT also has an isoenzyme for the bone  General Classification - Hydrolases  How to know where the specific problem is  Nonspecific enzyme (liver or bone) because we have 2 specific o Able to react with a variety of substrate enzymes for them?  Magnesium as activator (cofactor) o Run together with the other enzymes to  ALP contains zinc identify if liver or bone ang disorder o People who have a deficiency in zinc will  ALP is more prominent on obstructive jaundice have a falsely low result kaysa sa hepatocellular diseases (hepatitis or  Major sclerosis) o Intestine  AST and ALT mo increase kung hepatocellular o Liver pero normal to slight increase in obstruction o Bone o Placenta  Minor Major Isoenzymes o Kidney o Spleen  Liver ALP  Significance  Bone ALP o Evaluation of hepatobiliary disorder and  Placental ALP Bone disorder (Paget’s disease)  Intestinal ALP  Regan Note: o Lung cancer o Breast cancer  ALP – ALKALINE PHOSPHATASE o Ovarian cancer  Catalytic reaction o colon cancer o Liberate inorganic phosphate from  Nagao organic phosphate producing alcohol o People having pancreatic cancer via hydrolysis (introduction of water) o bile duct cancer  Catalytic reaction happens in the pH 9-10 o Reason why ALP is enzymatically active Note: or physiologically active because its alkaline pH  Liver ALP – is found on biliary ducts  ALP is different with acid phosphatase where it  Bone ALP – found in osteoblast catalyzes same reaction but with an acid pH o For children, alkaline phosphate is  Cofactor: magnesium higher because of osteoblastic activity o In older people, alkaline phosphate is  Contains zinc (people who have deficiency zinc also higher because of osteoblastic naay falsely low ALP) activity  Significance: CC2 Lab – Prelims – PART 3 Ma’am Michelle Mabasa  Bone ALP takes part in the transport of calcium urea but but phenyl-  Placental ALP is detected in pregnant women low low alanine from 16 – 20 weeks inhibitio inhibiti o Persists throughout the pregnancy n by L- on by o It will return to normal 3-6 days after phenyl- l- alanine phenyl birth - o Placental ALP is lower than blood group alanin A or AB e  Intestinal ALP is detected on the blood group because of a secretor gene o Blood group B and O has a higher Methods of Determination concentration of intestinal ALP than A or 1. Electrophoresis – You can differentiate AB isoenzyme the use of electrophoresis. Check the o Involved in the transport of lipids mobility from cathode to anode:  Regan and Nagao – carcinoplacental isoenzyme  Liver - fastest o Carcino – isoenzymes occur in  Bone – 2nd neoplasms (active cell division)  Placenta -3rd (common in cancer)  Intestine – slowest o Placental – its activity is close to placental alkaline phosphatase enzyme Note: activity  Liver and Bone medyo close ang difference sa Alkaline Phosphatase Isoenzyme Characteristics electrophoresis maong lisod sila e differentiate Name of Isoenzyme  To improve the separation of liver and Characterist Hepatic Bone Intestinal Placental Other bone isoenzyme: ic  You can add lectin in wheat Heat Stable at Labile: Intermedi Stable at Rega germ Stability 56°C for disapp ate labile: 65°C forn  Or neuraminidase 30 ears at disappear 30 isoen minutes 56 °C s at 56°C minutes zyme 2. Heat Fractionation/Stability Test – 56 °C for 10 within within 15 : minutes 10 minutes most  Placenta – most heat stable minut stabl  It can resist denaturation up to es e 65°C up to 30 minutes Electroph Most Interm Cathodic Migrate Rena  This is also the same with oretic anodic ediate to bone s with l isoenzyme regan and nagao Order fraction hepatic isoen  Intestine or bone zyme  Liver forms : rare but  Bone – most heat labile most 3. Chemical Inhibition Test – inhibit the reaction cath  Phenylalanine: Common inhibitor odic  Inhibit: Chemical Modera Strong Strong  Placenta Inhibition te inhibiti inhibition  Regan inhibitio on by by l-  Nagao n by urea  Intestinal isoenzyme CC2 Lab – Prelims – PART 3 Ma’am Michelle Mabasa  Synthetic urea Note:  Inhibit:  There are also several tests/measurements that  Bone isoenzyme can be performed for alkaline phosphatase.  Levamisole  Remember that your alkaline  Inhibit: phosphatase is nonspecific, so it can  Liver isoenzyme react to several substrates.  Bone isoenzyme 4. Bowers and Mc Comb Methods Substrate End products Bodansky Beta- Inorganic PO4 + p-nitrophenylphosphate → p-nitrophenol + phosphate Shinowara glycerophosphate Glycerol ion Jones  p-nitrophenylphosphate – Blue Reinhart King and Phenylphosphate Phenol  p-nitrophenol – Yellow Armstrong Bessy, Lowry p-nitro phenyl PO4 p-nitrophenol and Brock or yellow Principle of Bowers and Mccomb: Bowers and p-nitro phenyl PO4 nitrophenoxide McComb ion  Its reaction is based on the hydrolytic reaction Huggins and Phenolphthalein Phenolphthalein  Breakdown of p-nitrophenylphosphate Talalay diphosphate red because of hydrolysis, so there is water Moss Alpha naphthol Alpha - in the reaction. PO4 Naphthol  p-nitrophenylphosphate is colorless and once it Klein, Babson Buffered Free is hydrolysed, it will be liberated and the p- & Read Phenolphthalein Phenolphthalein nitrophenol and phosphate ion will become PO4 color yellow.  The absorbance activity of the yellow color change of the p-nitrophenol will be Laboratory Considerations measured at 405 nm and the increase in 1. Hemolysis the absorbance of the liberated p-  Old samples are prohibited nitrophenol at the 405 nm is directly 2. Serum or heparinized plasma less than 3 hours proportional to your ALP activity. old  The higher the absorbance, the higher  3 hours is the maximum because the the ALP activity. longer it stands, the more the pH will increase, and the more active the  Absorbance measure: 405 nm alkaline phosphatase.  pH: 10.15 3. Anticoagulants that remove calcium and magnesium will prevent product formation  Remember that magnesium is your co- factor.  So, if magnesium is inhibited by the anticoagulant, there will be no activator or no product formation. CC2 Lab – Prelims – PART 3 Ma’am Michelle Mabasa 4. Lipids, hemoglobin or Bilirubin interferences GGT  Remember that our absorbance (gamma-glutamyl transferase) measurement in Bower and Mccomb is 405. (EC 2.3.2.2)  These substances can absorb light at 405 nm that is why, they can interfere with  It is classified as transaminase or transferase. the result.  Catalytic reaction: Transfers itself to amino  Hemolyzed samples should not be used acids, other peptides or water molecules because of the free hemoglobin.  Distribution 5. Fasting  Kidney  It would be ideal if the patient is fasting  Brain because remember in the intestinal  Prostate alkaline phosphatase isoenzyme, after  Pancreas every meal, it would increase.  Liver  To avoid false increase due to  Significance food ingestion, it is ideal that the  Evaluation of liver damage patient will fast.  This is because in all 6. Temperature sensitive hepatobiliary disorder, GGT will  At 4˚C, it would falsely elevate ALP increase. That is why, it is the activity. most sensitive liver enzyme 7. Zinc deficiency assay in all hepatobiliary  For those who have deficiency in zinc, disorder—either obstruction or they will have a low ALP because zinc is functional. part of the ALP enzyme.  There is also a higher elevation Note: of GGT in obstruction just like in the ALT. Hyphosphatasia (low ALP)  Detection of alcoholism  A genetic disorder wherein there is an  GGT is elevated in alcoholism. abnormal development of the bones and  Monitoring of alcohol intake by patients the teeth.  GGT is used if the patient has Low ALP can also be found in patients after blood already abstained from alcohol transfusion. within 2-3 weeks, GGT will The reaction/testing process of ALP can be normalize. inhibited by phosphorus. Placental ALP is a good tumor marker for germ Note: cell tumor (those in the gonads).  For patients taking enzyme inducing drugs, such  If the patient is pregnant, expect an as: increase of the placental ALP, not  Phenytoin because of the tumor marker.  Phenobarbital  Warfarin  These can lead to an increase in the GGT, not because of damaged liver, but because of the location of the GGT. CC2 Lab – Prelims – PART 3 Ma’am Michelle Mabasa  GGT is in the canaliculi of the Methods of Determination liver cells, particularly in the smooth endoplasmic reticulum.  Methods  So, any mitochondrial induction  Szass (the mitochondira of the cell),  Rosalki & Tarrow the activity of GGT will be  Orlowski triggered and it will increase.  Substrate  Aside from the liver damage, GGT is also  Gamma-glutamyl-p-nitroanilide elevated in the ACUTE PANCREATITIS  Remember that a substrate is  This is because GGT can also be found in the one that is acted upon an the pancreas. enzyme.  For patients experiencing DIABETES  Once an enzyme is acted upon a MILLETUS, since the injury is in the substrate, the substrate (y- pancreas, GGT will increase. Glutamyl-p- nitroanilide) will be  Patients who are experiencing PROSTATIC converted into Glycylglycine. DISORDER, it will also elevate.  And then, Glycylglycine will be  Patients who are experiencing ACUTE liberated into a para-nitroaniline MYOCARDIAL INFARCTION, GGT will also increase.  Product  However, there is no explanation behind  P-nitroaniline this since there is no heart in the tissue  The activity/appearance of the distribution. p-nitroaniline, which is a  GGT is also useful in differentiating the ALP chromorgenic product, so its increase. absorbance would be measures  Remember that when there is a problem at 405-420 nm, pwede na dayon in the liver and bone (skeletal muscle), ma measure ang kani na ALP will increase. chromogenic product.  In the GGT  The method of measuring can  If there is a problem in the liver, be: it will increase.  END POINT: Remember  If there is a problem in the bone, endpoint, it measures it will be normal. only one which takes  If ALP is increased and GGT is normal, time for testing. then the problem will point in the  KINETIC BONE. So, this will be the diagnostic  CONTINUOS purpose of the GGT.  Reference Value  M: 6-45 U/L  F: 5-30 U/L  As you can observe, females has lower reference value. This is because they have Estrogen and Progesterone and these hormones may suppress the activity of GGT. CC2 Lab – Prelims – PART 3 Ma’am Michelle Mabasa Laboratory Considerations Other Clinically Significant Enzymes 1. Basically, GGT is STABLE. Acid Phosphatase  It is not affected by hemolysis ACP (EC 3.1.3.2)  You can put this in the refrigerator  You can store this at 4˚C  Catalyze same reaction as ALP but active at pH 5  Same catalytic reaction with ALP wherein inorganic phosphate or 5’ Nucleotidase phosphorus is liberated from the organic (EC 3.1.3.5) and it produces alcohol.  A phosphoric monoester hydrolase  However, the difference here is that:  Predominantly secreted in the liver  ALP has a pH of 9-10.  Diagnostic Significance  ACP has an acidic pH of 5.  Hepatobiliary disease (marker)  Significant levels found in:  RBC Note:  Platelet  In adult men, 50% found in the prostate  It is also a marker for infiltrative lesions of the gland liver.  That is why, one of its diagnostic  5’N also increases in Cholestatic disorders value is detecting prostatic  Stop/minimizes the production of the cancer or recurrence of the bile prostatic cancer together with  This will help in differentiating the liver and the the prostatic antigen test. bone problems in the alkaline phosphatase.  Isoenzymes fractioned into 5 bands  The same with GGT, this would increase  Band 1 (B1) in the liver, but normal in the bone.  Found in the PROSTATE - ACP is significant for detecting  Methods prostate cancer.  Dixon & Purdon  Band 2 (B2)  Campbell  Found in the WBC  Goldber (granulocytes)  Band 3 (B3)  Reference Value  Found in the:  0-1.6 units  Platelet - ACP increases if there is thrombocytopenia.  RBC - ACP increases when there is hemolytic anemia.  Monocyte  Band 4 (B4)  Found in the WBC (granulocytes) CC2 Lab – Prelims – PART 3 Ma’am Michelle Mabasa  Band 5 (B5) Laboratory Considerations  Found in the Osteoclast (bone) - ACP increases if there are  Free from hemolysis problems in the osteoclastic  Decreases when left at Room Temp activity.  If left at RT for 1-2 hours, decrease enzymatic activity  Aid in detecting:  pH will tend to rise  Metastatic CA  It will become alkaline  Other types of cancer and bone disease  The activity will decrease because it is  Forensic (rape cases) not physiologically active in an alkaline  Significant in rape cases because pH. ACP is found in the semen  Serum should be frozen or acidify  ACP is one of the proteolytic  If not run immediately, it should be enzymes that is part of the frozen or acidify semen.  Prostatic ACP is inhibited by L-tartrate ions  ACP can persist or its level can  Remember that Prostatic ACP is Band 1 still be detected until 4 days. isoenzyme  From vaginal washing.  RBC ACP is inhibited by formaldehyde  Remember that RBC ACP is Band 3 isoenzyme Methods of Determination  TRAP Methods Substrate End Product  Tartrate-Resistant Acid Phosphatase Gutman and Phenyl PO4 Inorganic PO4  Cannot be affected by L-tartrate ions Gutman inhibition Shinowara PNPP p-nitrophenol  This is present in people having: Babson, Read Alpha naphthyl Alpha-  Leukemia & Phillips PO4 napthol  Lymphoma Roy and Thymolphthalein Free  Elevated Serum Bilirubin Hillman monophosphate Thymolph  Cause a low value of TRAP activity Note:  TRAP is affected by bilirubin  Somehow same with the ALP because it is NON- Other Minor Liver Enzymes SPECIFIC enzyme.  Different substrates are present 1. ALDOLASE (4.1.1.13)  But, we will be using Kinetic/ Endpoint  Splits fructose testing.  Actually has 3 isoenzymes  ENDPOINT  ALD A  The substrate of the test will be:  Skeletal Muscle Thymolpthalein monophosphate.  ALD B:  KINETIC (continuous monitoring)  White Blood Cell  The substrate of the test is Alpha  Liver naphthyl PO4.  Kidney  Different substrate, different end product.  ALD C:  Brain tissue CC2 Lab – Prelims – PART 3 Ma’am Michelle Mabasa  A Lyases enzyme (4) 4. Ceruloplasmin  Its catalytic reaction is to breakdown  Copper-carrying protein fructose.  Marker for Wilson’s disease  Clinical Significance:  A genetic disorder wherein  Increase in problems in the: there is an excess storage of  Skeletal muscle copper which can lodge in the  Hepatic diseases eyes and brain.  Hemolytic anemia 5. Ornithine Carbamoyl Transferase  Leukemia (OCT) 2. Pseudocholinesterase (EC 3.1.1.8)  Marker for hepatobiliary diseases  A hydrolytic enzyme  Majority is in the liver, but it is not part 6. G-6-PD (EC 1.1.1.49) of the liver enzyme  An oxidoreductase  Because it reflects more on the  Functions to maintain or suppress the synthetic function rather than activity of NADPH in the RBC detoxification function.  Part of newborn screening because…  Remember, liver enzymes assess  In some genetic disorder, if they detoxification function. fail to produce the enzyme: G-  This is more of a marker in the: 6-PD, then it indicates that  Insecticide or rodenticide there is a problem in the RBC. poisoning  This is because G-6-PD can be  It will decrease in: found in the:  Acute hepatitis  Adrenal cortex  Cirrhosis  Spleen  Carcinoma  RBC  Malnutrition  Lymph nodes  Tissue Sources:  Deficiency of this enzyme will  Liver lead to hemolysis.  Myocardium  G-6-PD will increase in:  Pancreas  Myocardial infarction  Megaloblastic anemia 3. ACE (EC 3.4.15.1)  “Angiotensin-converting enzyme”  Converts angiotensin 1 into angiotensin 2  A hydrolase  Diagnostic Significance:  Diagnosis and monitoring of sarcoidosis  Abnormal collection of inflammatory cells.

Use Quizgecko on...
Browser
Browser